Literature DB >> 8496415

Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample.

F Schultz Larsen1.   

Abstract

BACKGROUND: Atopic dermatitis is a common multifactorial disease that seems to be increasing in frequency.
OBJECTIVE: Our purpose was to evaluate and expand previous findings on the incidence of atopic dermatitis and its concordance rates in twins.
METHODS: A mailed questionnaire study was conducted. It involved 812 twin pairs living in Fyn County, Denmark, as of Jan. 1, 1987 and born between 1965 and 1979. Zygosity was determined by the similarity method.
RESULTS: The response rate was 92%. The cumulative incidence rate (up to 7 years) of atopic dermatitis increased significantly from 0.06 for the birth cohort 1965-1969 to 0.12 for the birth cohort 1975-1979. The pairwise concordance rate was 0.72 in monozygotic and 0.23 in dizygotic twin pairs.
CONCLUSION: The frequency of atopic dermatitis is still increasing but not as rapidly as in the 1960s. The magnitude of the concordance rates indicates that genetic factors are decisive in the development of atopic dermatitis. It is suggested that widespread environmental factors are operating in genetically susceptible persons.

Entities:  

Mesh:

Year:  1993        PMID: 8496415     DOI: 10.1016/0190-9622(93)70099-f

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  37 in total

1.  Age at childhood infections and risk of atopy.

Authors:  P Bager; T Westergaard; K Rostgaard; H Hjalgrim; M Melbye
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 3.  Eczema in early life: genetics, the skin barrier, and lessons learned from birth cohort studies.

Authors:  Jocelyn M Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

4.  Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.

Authors:  I Lenoir-Wijnkoop; W M C van Aalderen; G Boehm; D Klaassen; A B Sprikkelman; M J C Nuijten
Journal:  Eur J Health Econ       Date:  2010-12-17

5.  A common variant on chromosome 11q13 is associated with atopic dermatitis.

Authors:  Jorge Esparza-Gordillo; Stephan Weidinger; Regina Fölster-Holst; Anja Bauerfeind; Franz Ruschendorf; Giannino Patone; Klaus Rohde; Ingo Marenholz; Florian Schulz; Tamara Kerscher; Norbert Hubner; Ulrich Wahn; Stefan Schreiber; Andre Franke; Rainer Vogler; Simon Heath; Hansjörg Baurecht; Natalija Novak; Elke Rodriguez; Thomas Illig; Min-Ae Lee-Kirsch; Andrzej Ciechanowicz; Michael Kurek; Tereza Piskackova; Milan Macek; Young-Ae Lee; Andreas Ruether
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

6.  [Genetics of atopic eczema. An update].

Authors:  E Rodríguez; S Weidinger
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 7.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 8.  The genetics of atopic dermatitis.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

9.  Reactions of ozone with human skin lipids: sources of carbonyls, dicarbonyls, and hydroxycarbonyls in indoor air.

Authors:  Armin Wisthaler; Charles J Weschler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

10.  Ethical issues of genetic susceptibility testing for occupational diseases: opinions of trainees in a high-risk job.

Authors:  M J Visser; M D F Rhebergen; S Kezic; F J H van Dijk; D L Willems; M M Verberk
Journal:  Int Arch Occup Environ Health       Date:  2012-09-25       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.